| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $160.2M | -17.7% |
| Cost of Revenue | $63.2M | -14.8% |
| R&D Expense | $37.7M | -40.3% |
| SG&A Expense | $106.5M | +6.3% |
| Operating Income | -$50.5M | -9.1% |
| Pre-tax Income | -$69.4M | -33.7% |
| Net Income | -$69.4M | -33.7% |
| EPS (Basic) | -$0.33 | -17.9% |
| EPS (Diluted) | -$0.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.9M | +20.8% |
| Accounts Receivable | $34.4M | -12.5% |
| Inventory | $16.2M | +3.5% |
| Current Assets | $113.8M | -3.7% |
| Total Assets | $220.7M | -8.7% |
| Current Liabilities | $80.9M | -19.0% |
| Long-term Debt | $38.7M | +11.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.7M | -73.9% |
| Capital Expenditures | $33K | — |
| Investing Cash Flow | -$33K | — |
| Financing Cash Flow | $49.7M | +297.0% |
| Free Cash Flow | -$40.7M | -74.0% |
| -17.9% |
| Total Liabilities |
| $269.9M |
| -0.9% |
| Stockholders' Equity | -$49.2M | -60.8% |